MedTrace Logo

Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds

NCT01268189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-10-09

Study results available
· View outcomes & findings →

Summary

This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean healing time for wounds treated with the OxyBand dressing will be less than the mean healing time for wounds treated with the Xeroform dressing.

Conditions

  • Burns

Interventions

DEVICE

Oxygen diffusing dressing

Oxygen diffusing dressing applied to study wound

DEVICE

Standard of care dressing

Xeroform control dressing applied to control wound

Sponsors & Collaborators

  • United States Army Institute of Surgical Research

    lead FED

Principal Investigators

  • Kimberly F Lairet, MD · US Army Institute of Surgical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268189 on ClinicalTrials.gov